https://www.selleckchem.com/pr....oducts/dual-specific
our.[This corrects the article on p. 156 in vol. 16, PMID 7536728.]. The L. leaf is gaining interest as a potential therapeutic agent for alleviating dengue- and non-dengue-associated thrombocytopaenia. In that regard, safety considerations are as important as efficacy potential. The safety evaluation of botanical products for human use is complicated by variable formulations, complex phytochemical composition, and extrinsic toxicants. This review aimed to systematically collate related saf